| 1 |
Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection |
|
|
| Xiaofeng Lu, Xianlu Zeng, Miaohong Chen, Zixin Fan, Lei Zheng, Ya Tian, Shaochong Zhang, Ji C. He, Guoming Zhang |
|
| Graefe's Archive for Clinical and Experimental Ophthalmology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity |
|
|
| Vasumathy Vedantham |
|
| Journal of Clinical Ophthalmology and Research. 2022; 10(2): 77 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Treatment outcomes of combination of anti-vascular endothelial growth factor injection and laser photocoagulation in Type 1 ROP and APROP |
|
|
| Parveen Sen, Aditi Ashok Kumar Agarwal, Pramod Bhende, Suganeswari Ganesan |
|
| International Ophthalmology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Complications of retinopathy of prematurity treatment |
|
|
| Joshua M. Barnett, G. Baker Hubbard |
|
| Current Opinion in Ophthalmology. 2021; 32(5): 475 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review |
|
|
| Soumya Narayana, Mohammed Gulzar Ahmed, B. H. Jaswanth Gowda, Pallavi K. Shetty, Arfa Nasrine, M. Thriveni, Nadira Noushida, A. Sanjana |
|
| Future Journal of Pharmaceutical Sciences. 2021; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
A safety review of drugs used for the treatment of retinopathy of prematurity |
|
|
| Luca Filippi, Massimo Dal Monte |
|
| Expert Opinion on Drug Safety. 2020; 19(11): 1409 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity |
|
|
| Mari Jeeva Sankar, Jhuma Sankar, Parijat Chandra |
|
| Cochrane Database of Systematic Reviews. 2018; 2018(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Anti–Vascular Endothelial Growth Factor Medications in Retinopathy of Prematurity |
|
|
| Ana M. Suelves, Julia P. Shulman |
|
| Advances in Ophthalmology and Optometry. 2017; 2(1): 75 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Intravitreal bevacizumab alters type IV collagenases and exacerbates arrested alveologenesis in the neonatal rat lungs |
|
|
| Arwin M. Valencia, Charles L. Cai, Jeffrey Tan, Thomas J. Duggan, Gloria B. Valencia, Jacob V. Aranda, Kay D. Beharry |
|
| Experimental Lung Research. 2017; 43(3): 120 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Intravitreal Anti-VEGF Therapy as a Treatment for Retinopathy of Prematurity: What We Know After 7 Years |
|
|
| Michael A. Klufas,R. V. Paul Chan |
|
| Journal of Pediatric Ophthalmology & Strabismus. 2015; 52(2): 77 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity |
|
|
| Muhammet Kazim Erol, Deniz Turgut Coban, Özdemir Özdemir, Zuhal Özen Tunay, Ahmet Burak Bilgin, Berna Dogan |
|
| Journal of Pediatric Ophthalmology & Strabismus. 2015; 52(3): 152 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Intravitreal Bevacizumab in Retinopathy of Prematurity |
|
|
| Dini Hapsari,Rita S. Sitorus |
|
| Asia-Pacific Journal of Ophthalmology. 2014; 3(6): 368 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
The Biology of Retinopathy of Prematurity |
|
|
| Lois E. Smith,Anna-Lena Hard,Ann Hellström |
|
| Clinics in Perinatology. 2013; 40(2): 201 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Protocolo de tratamiento de la retinopatía del prematuro en España |
|
|
| C. Ferrer Novella,I. González Viejo,V. Pueyo Royo,R. Martínez Fernández,M. Galdós Iztueta,J. Peralta Calvo,J. Abelairas Gómez,P. Tejada Palacios,N. Martín Begué,Ch. Wolley-Dod,S. Alarcón Portabella,A. Serra Castanera,M. Morales Ballús,M.A. Harto Castaño,R. Martinez-Costa Perez,F.J. Rodriguez-Hurtado,J.L. García Serrano,J. Escudero Gómez,C. Morales Guillén,M.T. Pastor Ramos,A. Galván Ledesma,B. Balboa Huguet,E. García Robles,J.M. Gallardo Galera,B. Cabrera Marrer,J. Castellano Solanes,L. Cordovés Dorta,P. Vals Quintana,M.A. Gil Hernandez,S. Perez-Torres,L. Cortazar Galarza,M.A. Ardanaz Aldave,M. Bové Guri,M.J. Blanco Teijeiro,P. Mera Yañez,J. Garcia Campos |
|
| Archivos de la Sociedad Española de Oftalmología. 2013; 88(6): 231 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
A protocol for the treatment of retinopathy of prematurity in Spain |
|
|
| C. Ferrer Novella,I. González Viejo,V. Pueyo Royo,R. Martínez Fernández,M. Galdós Iztueta,J. Peralta Calvo,J. Abelairas Gómez,P. Tejada Palacios,N. Martín Begué,Ch. Wolley-Dod,S. Alarcón Portabella,A. Serra Castanera,M. Morales Ballús,M.A. Harto Castaño,R. Martinez-Costa Perez,F.J. Rodriguez-Hurtado,J.L. García Serrano,J. Escudero Gómez,C. Morales Guillén,M.T. Pastor Ramos,A. Galván Ledesma,B. Balboa Huguet,E. García Robles,J.M. Gallardo Galera,B. Cabrera Marrer,J. Castellano Solanes,L. Cordovés Dorta,P. Vals Quintana,M.A. Gil Hernandez,S. Perez-Torres,L. Cortazar Galarza,M.A. Ardanaz Aldave,M. Bové Guri,M.J. Blanco Teijeiro,P. Mera Yañez,J. Garcia Campos |
|
| Archivos de la Sociedad Española de Oftalmología (English Edition). 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity |
|
|
| Sengul Ozdek,Metin Unlu,Gokhan Gurelik,Berati Hasanreisoglu |
|
| Journal of Optometry. 2013; 6(1): 51 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Risk Factors for Retinopathy of Prematurity: Beyond Age, Birth Weight, and Oxygen |
|
|
| Iason S. Mantagos,Deborah K. VanderVeen,Lois E. H. Smith |
|
| Current Ophthalmology Reports. 2013; 1(4): 213 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report |
|
|
| Hae Jung Sun,Kyung Seek Choi,Sung Jin Lee |
|
| Japanese Journal of Ophthalmology. 2012; 56(5): 476 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series |
|
|
| Carlo Dani,Saverio Frosini,Pina Fortunato,Giovanna Bertini,Simone Pratesi,Liliana Pollazzi,Roberto Caputo,Agostino La Torre |
|
| Journal of Maternal-Fetal and Neonatal Medicine. 2012; 25(11): 2194 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Effect of Laser Photocoagulation and Intravitreal Bevacizumab Injection on Zone I Retinopathy of Prematurity |
|
|
| Won Choi, Hwan Heo |
|
| Journal of the Korean Ophthalmological Society. 2012; 53(1): 120 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 21 |
Interventions in Retinopathy of Prematurity |
|
|
| R. A. Silva,D. M. Moshfeghi |
|
| NeoReviews. 2012; 13(8): e476 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease : |
|
|
| Hamid Hosseini, Mohammad H Nowroozzadeh, Ramin Salouti, Mahmood Nejabat |
|
| Cornea. 2012; 31(3): 322 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 23 |
Phacoemulcification with Intravitreal Bevacizumab Injection in Patients with Cataract and Coexisting Diabetic Retinopathy: Prospective Randomized Study |
|
|
| Ali Salehi,Afsaneh Naderi Beni,Hassan Razmjoo,Zahra Naderi Beni |
|
| Journal of Ocular Pharmacology and Therapeutics. 2012; 28(3): 212 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY : |
|
|
| Ruth Axer-Siegel, Moshe Snir, Yonina Ron, Ronit Friling, Lea Sirota, Dov Weinberger |
|
| Retina. 2011; 31(7): 1239 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 25 |
Rescue Intravitreal Bevacizumab (Avastin) for Aggressive Posterior Retinopathy of Prematurity |
|
|
| Farhan Qureshi, Christopher Dewhurst, C.W. Yoxall, David Clark |
|
| Seminars in Ophthalmology. 2011; 26(2): 55 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 26 |
Mediators involved in retinopathy of prematurity and emerging therapeutic targets |
|
|
| A. Mataftsi, S.A. Dimitrakos, G.G.W. Adams |
|
| Early Human Development. 2011; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 27 |
Intravitreal Bevacizumab for Retinopathy of Prematurity |
|
|
| Björn C. Harder, Stefan von Baltz, Jost B. Jonas, Frank C. Schlichtenbrede |
|
| Journal of Ocular Pharmacology and Therapeutics. 2011; 27(6): 623 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 28 |
Visual acuity and electroretinography findings 3 1/2 years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity |
|
|
| Shah, P.K., Morris, R.J., Narendran, V., Kalpana, N. |
|
| Indian Journal of Ophthalmology. 2011; 59(1): 73-74 |
|
| [Pubmed] [Google Scholar] |
|
| 29 |
Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage |
|
|
| Hossein Nazari, Mehdi Modarres, Mohammad Mehdi Parvaresh, Khalil Ghasemi Falavarjani |
|
| Graefe s Archive for Clinical and Experimental Ophthalmology. 2010; 248(12): 1713 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 30 |
Intravitreal cysticercosis presenting as neovascular glaucoma |
|
|
| Ratra, D., Phogat, C., Singh, M., Choudhari, N.S. |
|
| Indian Journal of Ophthalmology. 2010; 58(1): 70-73 |
|
| [Pubmed] [Google Scholar] |
|
| 31 |
Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity |
|
|
| Law, J.C., Recchia, F.M., Morrison, D.G., Donahue, S.P., Estes, R.L. |
|
| Journal of AAPOS. 2010; 14(1): 6-10 |
|
| [Pubmed] [Google Scholar] |
|
| 32 |
New progress on the treatment of retinopathy of prematurity |
|
|
| Tan, J.-X., Zhu, D. |
|
| International Journal of Ophthalmology. 2010; 10(5): 898-900 |
|
| [Pubmed] [Google Scholar] |
|
| 33 |
Pharmacological treatment of retinopathy of prematurity: Antiangiogenic or proangiogenic? |
|
|
| Uemura, A. |
|
| Expert Review of Ophthalmology. 2010; 5(2): 123-127 |
|
| [Pubmed] [Google Scholar] |
|
| 34 |
Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity |
|
|
| Janice C. Law,Franco M. Recchia,David G. Morrison,Sean P. Donahue,Robert L. Estes |
|
| Journal of American Association for Pediatric Ophthalmology and Strabismus. 2010; 14(1): 6 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Pharmacological treatment of retinopathy of prematurity: antiangiogenic or proangiogenic? |
|
|
| Akiyoshi Uemura |
|
| Expert Review of Ophthalmology. 2010; 5(2): 123 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 36 |
Antivascular endothelial growth factor for retinopathy of prematurity |
|
|
| Helen A Mintz-Hittner,Leah M Best |
|
| Current Opinion in Pediatrics. 2009; 21(2): 182 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Retinopathy of Prematurity: Clinical Insights from Molecular Studies |
|
|
| G. Heidary,C. Lofqvist,I. S. Mantagos,D. K. Vanderveen,A. Hellstrom,L. E. Smith |
|
| NeoReviews. 2009; 10(11): e550 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity |
|
|
| Jonathan A. Micieli,Michael Surkont,Andrew F. Smith |
|
| American Journal of Ophthalmology. 2009; 148(4): 536 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Retinopathy of Prematurity |
|
|
| Debbie Fraser Askin,William Diehl-Jones |
|
| Critical Care Nursing Clinics of North America. 2009; 21(2): 213 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Bevacizumab (Avastin) for the Treatment of Ocular Disease |
|
|
| Jonathan B. Gunther,Michael M. Altaweel |
|
| Survey of Ophthalmology. 2009; 54(3): 372 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema |
|
|
| |
|
| Ophthalmology. 2009; 116(8): 1488 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 42 |
Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity |
|
|
| P K Shah,V Narendran,N Kalpana,K A Tawansy |
|
| Eye. 2009; 23(1): 176 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Effect of intravitreal bevacizumab (Avastin) on the growing rabbit eye |
|
|
| Axer-Siegel, R., Herscovici, Z., Hasanreisoglu, M., Kremer, I., Benjamini, Y., Snir, M. |
|
| Current Eye Research. 2009; 34(8): 660-665 |
|
| [Pubmed] [Google Scholar] |
|
| 44 |
A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity |
|
|
| Micieli, J.A., Surkont, M., Smith, A.F. |
|
| American Journal of Ophthalmology. 2009; 148(4): 536-543, e2 |
|
| [Pubmed] [Google Scholar] |
|
| 45 |
Retinopathy of prematurity: Clinical insights from molecular studies |
|
|
| Heidary, G., Löfqvist, C., Mantagos, I.S., Vanderveen, D.K., Hellström, A., Smith, L.E. |
|
| NeoReviews. 2009; 10(11): e550-e557 |
|
| [Pubmed] [Google Scholar] |
|
| 46 |
New therapeutic approaches in the treatment of retinopathy of prematurity | [Neue therapeutische Ansätze in der Behandlung der Frü hgeborenenretinopathie] |
|
|
| Jandeck, C. |
|
| Klinische Monatsblatter fur Augenheilkunde. 2009; 226(11): 914-920 |
|
| [Pubmed] [Google Scholar] |
|
| 47 |
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema. The Pan-American Collaborative Retina Study Group at 24 Months |
|
|
| Arevalo, J.F., Sanchez, J.G., Wu, L., Maia, M., Alezzandrini, A.A., Brito, M., Bonafonte, S., (...), Udaondo-Mirete, P. |
|
| Ophthalmology. 2009; 116(8): 1488-1497,e1 |
|
| [Pubmed] [Google Scholar] |
|
| 48 |
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up |
|
|
| Arevalo, F., Sanchez, J.G., Fromow-Guerra, J., Wu, L., Berrocal, M.H., Farah, M.E., Cardillo, J., Rodríguez, F.J. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2009; 247(6): 735-743 |
|
| [Pubmed] [Google Scholar] |
|
| 49 |
Retinopathy of Prematurity |
|
|
| Askin, D.F., Diehl-Jones, W. |
|
| Critical Care Nursing Clinics of North America. 2009; 21(2): 213-233 |
|
| [Pubmed] [Google Scholar] |
|
| 50 |
Bevacizumab (Avastin) for the Treatment of Ocular Disease |
|
|
| Gunther, J.B., Altaweel, M.M. |
|
| Survey of Ophthalmology. 2009; 54(3): 372-400 |
|
| [Pubmed] [Google Scholar] |
|
| 51 |
Antivascular endothelial growth factor for retinopathy of prematurity |
|
|
| Mintz-Hittner, H.A., Best, L.M. |
|
| Current Opinion in Pediatrics. 2009; 21(2): 182-187 |
|
| [Pubmed] [Google Scholar] |
|
| 52 |
Emerging treatments for retinopathy of prematurity |
|
|
| Mantagos, I.S., Vanderveen, D.K., Smith, L.E.H. |
|
| Seminars in Ophthalmology. 2009; 24(2): 82-86 |
|
| [Pubmed] [Google Scholar] |
|
| 53 |
Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity |
|
|
| Shah, P.K., Narendran, V., Kalpana, N., Tawansy, K.A. |
|
| Eye. 2009; 23(1): 176-180 |
|
| [Pubmed] [Google Scholar] |
|
| 54 |
Retinopathy of Prematurity: Current Understanding and Treatment |
|
|
| Hee Yoon Cho |
|
| Hanyang Medical Reviews. 2009; 29(4): 362 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
Intravitreal bevacizumab for neovascular glaucoma |
|
|
| Andrijević-Derk, B., Vatavuk, Z., Benčić, G., Novak-Lauš, K., Mandić, Z. |
|
| Acta Clinica Croatica. 2008; 47(3): 175-179 |
|
| [Pubmed] [Google Scholar] |
|
| 56 |
Surgical management of retinopathy of prematurity |
|
|
| Hubbard, G.B. |
|
| Current Opinion in Ophthalmology. 2008; 19(5): 384-390 |
|
| [Pubmed] [Google Scholar] |
|
| 57 |
Effect of bevacizumab (avastin) on eye diseases |
|
|
| Song, H., Ren, B., Gao, X.-W. |
|
| International Journal of Ophthalmology. 2008; 8(6): 1230-1232 |
|
| [Pubmed] [Google Scholar] |
|
| 58 |
Retinal detachment in children: Differential diagnosis and current therapy | [Netzhautablösung im kindesalter: Differenzialdiagnose und aktuelle therapieoptionen] |
|
|
| Meier, P. |
|
| Klinische Monatsblatter fur Augenheilkunde. 2008; 225(9): 779-790 |
|
| [Pubmed] [Google Scholar] |
|
| 59 |
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity |
|
|
| Honda, S., Hirabayashi, H., Tsukahara, Y., Negi, A. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2008; 246(7): 1061-1063 |
|
| [Pubmed] [Google Scholar] |
|
| 60 |
Progress of researches on Avastin in ophthalmology |
|
|
| Yu, T.-L., Bi, H.-S. |
|
| International Journal of Ophthalmology. 2008; 8(4): 810-812 |
|
| [Pubmed] [Google Scholar] |
|
| 61 |
Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization |
|
|
| Ahmad M. Mansour,Friederike Mackensen,J. Fernando Arevalo,Focke Ziemssen,Padmamalini Mahendradas,Abla Mehio-Sibai,Nicholas Hrisomalos,Timothy Y.Y. Lai,David Dodwell,Wai-Man Chan,Thomas Ness,Alay S. Banker,Sivakami A. Pai,Maria H. Berrocal,Rania Tohme,Arnd Heiligenhaus,Ziad F. Bashshur,Moncef Khairallah,Khalil M. Salem,Frank N. Hrisomalos,Matthew H. Wood,Wilson Heriot,Alfredo Adan,Atul Kumar,Lyndell Lim,Anthony Hall,Matthias Becker |
|
| American Journal of Ophthalmology. 2008; 146(3): 410 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 62 |
Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. |
|
|
| MINTZ-HITTNER, H.A. and KUFFEL JR, R.R. |
|
| Retina. 2008; 28(6): 831 |
|
| [Pubmed] [Google Scholar] |
|
| 63 |
Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization |
|
|
| Mansour, A.M. and Mackensen, F. and Arevalo, J.F. and Ziemssen, F. and Mahendradas, P. and Mehio-Sibai, A. and Hrisomalos, N. and Lai, T.Y.Y. and Dodwell, D. and Chan, W.M. and others |
|
| American Journal of Ophthalmology. 2008; 146(3): 410-416 |
|
| [Pubmed] [Google Scholar] |
|
| 64 |
INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II |
|
|
| HELEN A. MINTZ-HITTNER,RONALD R. KUFFEL |
|
| Retina. 2008; 28(6): 831 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 65 |
Surgical management of retinopathy of prematurity |
|
|
| G Baker Hubbard |
|
| Current Opinion in Ophthalmology. 2008; 19(5): 384 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 66 |
Bevacizumab for ophthalmic diseases |
|
|
| Stephan Michels, Franz Prager, Sophie J Bakri, Joachim Wachtlin |
|
| Expert Review of Ophthalmology. 2007; 2(3): 369 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 67 |
Combination of laser photocoagulation and intravitreal bevacizumab (Avastin{\textregistered}) for aggressive zone I retinopathy of prematurity |
|
|
| Chung, E.J. and Kim, J.H. and Ahn, H.S. and Koh, H.J. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2007; 245(11): 1727-1730 |
|
| [Pubmed] [Google Scholar] |
|
| 68 |
Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population |
|
|
| Kumar, A. and Sinha, S. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 451 |
|
| [Pubmed] [Google Scholar] |
|
| 69 |
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration |
|
|
| Azad, R. and Chandra, P. and Gupta, R. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 441 |
|
| [Pubmed] [Google Scholar] |
|
| 70 |
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice |
|
|
| Hussain, N. and Ghanekar, Y. and Kaur, I. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 445 |
|
| [Pubmed] [Google Scholar] |
|
| 71 |
Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity |
|
|
| Azad, R., Chandra, P. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 319 |
|
| [Pubmed] [Google Scholar] |
|
| 72 |
Authorsæ reply |
|
|
| Shah, P.K., Narendran, V., Tawansy, K.A., Raghuram, A., Narendran, K. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 317-318 |
|
| [Pubmed] [Google Scholar] |
|
| 73 |
Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity |
|
|
| Sangtam, T., Vinekar, A., Maheshwar, B., Dogra, M.R., Eong, K.-G.A. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 317 |
|
| [Pubmed] [Google Scholar] |
|
| 74 |
Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries |
|
|
| Velpandian, T. and Sharma, C. and Garg, SP and Mandal, S. and Ghose, S. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 488 |
|
| [Pubmed] [Google Scholar] |
|
| 75 |
Off-label use of medicines: Medical research and medical practice |
|
|
| Khamar, B. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 411 |
|
| [Pubmed] [Google Scholar] |
|
| 76 |
Intravitreal bevacizumab: an analysis of the evidence |
|
|
| Smit, D.P. and Meyer, D. |
|
| Clinical Ophthalmology. 2007; 1(3): 273-284 |
|
| [Pubmed] [Google Scholar] |
|
.png "Santen")
